Participated · Equity · Jul 2026

LimX Dynamics develops an integrated embodied AI stack and general-purpose humanoid robots, organizing its architecture into System 0 (whole-body motion control), System 1 (Vision-Language-Action and Whole-Body Action Model training infrastructure, including the FluxVLA Engine) and System 2 (the COSA embodied agentic operating system). The company introduced the full-size interactive humanoid LimX Luna in May 2026 and began customer deliveries in China and international markets within weeks of launch, and also offers TRON 2, a modular robotic platform launched in late 2025. LimX reports thousands of customer orders across its product lines since beginning commercial sales, with more than half of those orders from international markets. Target applications include research, education, commercial services, industrial operations, inspection and construction. Financially, LimX has raised roughly $400 million over the past six months, including the nearly $200 million pre-IPO round, and plans to use proceeds to scale manufacturing, expand delivery capacity and accelerate international commercialization.

Participated · Series A · Mar 2026

AeroBand began from a student founding team in 2015 and is led by founder 牛亚锋, who holds a master’s in control science and engineering from University of Science and Technology Beijing. The company positions itself to lower the barrier for nonprofessional users to engage with musical instruments via integrated hardware, software and content. Since launching its core product in 2024, AeroBand says it has helped hundreds of thousands of users rediscover guitar, with cumulative user time exceeding 1.4 million hours. By 2025 the brand reported nearly 2 billion cumulative global impressions, about 2.4 million social media followers, and product availability in over 200 countries and regions. The company plans to continue investing in core intelligent-instrument R&D, expand its product lineup, and scale global operations and talent hiring.

Participated · Equity · Jun 2024

HydroX AI develops an AI TRiSM platform to evaluate and manage LLM safety, security, privacy and integrity. Its flagship product, EPASS, is an evaluation platform that provides precision assessments, detailed reports, a management dashboard, and a leaderboard ranking models across over 30 safety and security categories. EPASS is designed to integrate into existing workflows for real-time monitoring, model comparison, and continuous improvement. The company announced the official launch of EPASS while in early development and engaging with major LLM companies. HydroX AI plans to use the $4M angel funding to continue LLM safety innovation, validate market need, and advance the platform’s market entry. The company was founded by Zhuo Li and is based in San Jose, CA.

Participated · Seed · Apr 2024

Ord.io announced a $2M pre-seed round in a LinkedIn post. The post names participating investors and backers but does not describe the company’s product, roadmap, or operating metrics. The announcement lists co‑lead investors and numerous participating funds and individuals. No financial metrics, revenue, user counts, or use-of-proceeds details were disclosed in the post. The LinkedIn post serves as the sole source for the company’s publicly shared fundraising information in the provided article. Additional context about Ord.io’s business model, team background, or future plans was not included in the article.

Participated · Series A · Aug 2023

一兮生物 is a synthetic biology company focused on technology innovation and product R&D. The company was among the first in China to industrialize human milk oligosaccharides (HMOs). Its core capability centers on the industrial-scale production of HMOs. In August 2023 it completed a nearly ¥100 million Pre-A+ financing round. The round was led by Huangpu Medical Fund and followed by Yuanhe Holdings, Junzilan, Yizhan Capital, and Nanwan Baiao Fund. Existing shareholders Oasis Capital and Shen Gaoxin Investment also continued to participate in the financing.